BIOMARIN PHARMACEUTICAL INC Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for May 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 130.00 | 34,078 | 4,430,140 | 41,507 | 75.6 K to 41.5 K (-45.09 %) |
May 26 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | S | 126.11 | 1,500 | 189,157 | 31,758 | 30.3 K to 31.8 K (+4.96 %) |
May 26 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 126.55 | 1,625 | 205,647 | 39,245 | 40.9 K to 39.2 K (-3.98 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Buy | S | 124.77 | 2,059 | 256,905 | 75,585 | 73.5 K to 75.6 K (+2.80 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 122.78 | 1,722 | 211,427 | 77,644 | 79.4 K to 77.6 K (-2.17 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 51.26 | 88 | 4,511 | 79,366 | 79.3 K to 79.4 K (+0.11 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 122.78 | 207 | 25,415 | 12,756 | 13 K to 12.8 K (-1.60 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 124.78 | 1,864 | 232,584 | 76,746 | 78.6 K to 76.7 K (-2.37 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 122.78 | 2,036 | 249,980 | 78,610 | 80.6 K to 78.6 K (-2.52 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Sell | S | 125.26 | 2,558 | 320,415 | 69,226 | 71.8 K to 69.2 K (-3.56 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Payment of Exercise | F | 122.78 | 1,096 | 134,567 | 71,784 | 72.9 K to 71.8 K (-1.50 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 122.78 | 4,932 | 605,551 | 235,894 | 240.8 K to 235.9 K (-2.05 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 1,434 | 0 | 27,670 | 26.2 K to 27.7 K (+5.47 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 1,434 | 0 | 102,700 | 104.1 K to 102.7 K (-1.38 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 122.78 | 1,566 | 192,273 | 104,134 | 105.7 K to 104.1 K (-1.48 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 122.78 | 1,096 | 134,567 | 40,870 | 42 K to 40.9 K (-2.61 %) |
May 14 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 121.37 | 1,434 | 174,038 | 80,646 | 82.1 K to 80.6 K (-1.75 %) |
May 14 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 121.09 | 1,566 | 189,627 | 82,080 | 83.6 K to 82.1 K (-1.87 %) |
May 14 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 121.09 | 2,349 | 284,440 | 240,826 | 243.2 K to 240.8 K (-0.97 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 121.66 | 444 | 54,017 | 12,963 | 13.4 K to 13 K (-3.31 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 51.26 | 607 | 31,117 | 13,407 | 12.8 K to 13.4 K (+4.74 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 121.64 | 2,869 | 348,988 | 83,646 | 86.5 K to 83.6 K (-3.32 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 121.66 | 3,131 | 380,917 | 86,515 | 89.6 K to 86.5 K (-3.49 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Payment of Exercise | F | 121.66 | 1,696 | 206,335 | 72,880 | 74.6 K to 72.9 K (-2.27 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Grant | A | 51.26 | 730 | 37,422 | 74,576 | 73.8 K to 74.6 K (+0.99 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 121.66 | 5,479 | 666,575 | 243,175 | 248.7 K to 243.2 K (-2.20 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 121.66 | 679 | 82,607 | 41,966 | 42.6 K to 42 K (-1.59 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 121.66 | 2,088 | 254,026 | 105,700 | 103.6 K to 105.7 K (+2.02 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 1,912 | 0 | 26,236 | 24.3 K to 26.2 K (+7.86 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 1,912 | 0 | 107,788 | 109.7 K to 107.8 K (-1.74 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 389 | 0 | 24,324 | 23.9 K to 24.3 K (+1.63 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 389 | 0 | 109,700 | 110.1 K to 109.7 K (-0.35 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 51.26 | 389 | 19,942 | 110,089 | 109.7 K to 110.1 K (+0.35 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 37.46 | 8,671 | 324,816 | 2,166 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 37.46 | 808 | 30,268 | 1,355 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 28.23 | 5,258 | 148,433 | 0 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 28.23 | 2,642 | 74,584 | 978 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 21.51 | 3,125 | 67,219 | 0 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 21.51 | 625 | 13,444 | 0 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 38.59 | 12,502 | 482,452 | 0 | |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 119.20 | 388 | 46,248 | 42,645 | 43 K to 42.6 K (-0.90 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 119.14 | 33,631 | 4,006,794 | 43,033 | 76.7 K to 43 K (-43.87 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 37.46 | 8,671 | 324,816 | 76,664 | 68 K to 76.7 K (+12.75 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 37.46 | 808 | 30,268 | 67,993 | 67.2 K to 68 K (+1.20 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 28.23 | 5,258 | 148,433 | 67,185 | 61.9 K to 67.2 K (+8.49 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 28.23 | 2,642 | 74,584 | 61,927 | 59.3 K to 61.9 K (+4.46 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 21.51 | 3,125 | 67,219 | 59,285 | 56.2 K to 59.3 K (+5.56 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 21.51 | 625 | 13,444 | 56,160 | 55.5 K to 56.2 K (+1.13 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 38.59 | 12,502 | 482,452 | 55,535 | 43 K to 55.5 K (+29.05 %) |
May 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 51.26 | 943 | 48,341 | 43,033 | 42.1 K to 43 K (+2.24 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 23,218 | 149,988 | 0 | |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 114.98 | 3,505 | 402,992 | 248,654 | 252.2 K to 248.7 K (-1.39 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 114.98 | 23,218 | 2,669,517 | 33,258 | 56.5 K to 33.3 K (-41.11 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 23,218 | 149,988 | 56,476 | 33.3 K to 56.5 K (+69.81 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 51.26 | 908 | 46,547 | 252,159 | 251.3 K to 252.2 K (+0.36 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | S | 114.59 | 414 | 47,442 | 89,646 | 89.2 K to 89.6 K (+0.46 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 51.26 | 1,425 | 73,050 | 90,060 | 88.6 K to 90.1 K (+1.61 %) |